Fen Wang, Zhu Li, Xiang Long, Daying Wu, Xiuyu Cai, Qiushan He, Wanzhong Huang, Lue Zhou, Yalei Zhang, Shubin Wang. "Real-world efficacy and safety of iruplinalkib in ALK -positive advanced lung adenocarcinoma patients previously treated with lorlatinib.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.e20730